Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04668898 · ClinicalTrials.gov registry record
LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 203
- Enrollment target
NCT04668898 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 203 participants.
The verdict
NCT04668898 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 203 participants
- Enrollment target
Study Summary
Single site observational study focused on elucidating the genes and biochemical pathways involved in causing Parkinson disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2025-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04668898
The ClinicalTrials.gov registry entry for NCT04668898 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04668898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04668898 about?
NCT04668898 is a clinical study titled "LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease". Single site observational study focused on elucidating the genes and biochemical pathways involved in causing Parkinson disease.
What is the current status of trial NCT04668898?
This trial is currently completed. The enrollment target is 203 participants. The study started on 2019-04-01. Estimated completion is 2025-04-01.
Who is sponsoring clinical trial NCT04668898?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.